In short
Biologic treatment for arthritis blocks one specific messenger in the immune system rather than damping the whole system down. It is considered when inflammatory arthritis stays active on conventional tablets, and it begins with screening tests rather than a prescription.
Reviewed by Dr. Ashish Baweja, DM Clinical Immunology & Rheumatology, AIIMS Rishikesh · last updated October 2026
A biologic is a medicine grown from living cells that blocks one specific messenger in the immune system instead of damping the whole system down. Biologic treatment for arthritis is what gets considered when an inflammatory arthritis has stayed active despite conventional disease-modifying tablets, and the inflammation is still capable of damaging joints.
It is not a last resort and it is not a cure. It is the next step in a sequence, and the decision is rarely made at a first visit. It follows months of treatment with conventional drugs, a set of screening tests, and an honest look at how much disease is left. Most people with rheumatoid arthritis never reach this step, because methotrexate and its relatives control the disease well enough.
What follows is what these drugs are, what has to happen before the first dose, how treatment is given and monitored, and the specific things worth sorting out if you are being treated in India.
What a biologic actually is
Conventional disease-modifying drugs are small chemical molecules that you swallow. Biologics are large protein molecules manufactured in cell cultures, which is why they are injected under the skin or infused into a vein rather than taken as tablets: the digestive system would break them apart before they could work.
Each biologic is built against one target. Some block tumour necrosis factor, usually shortened to TNF, a signalling protein that drives inflammation in the joint lining. Others block interleukin-6, interleukin-17 or interleukin-23, remove the B cells that produce antibodies, or interrupt the handshake between two immune cells that starts an inflammatory response.
That precision is the whole idea. A steroid quietens inflammation everywhere in the body, which is why its side effects reach everywhere too. A biologic interrupts one pathway and leaves most of the rest of the immune system working, which is also why it does not remove infection risk altogether.
JAK inhibitors are a separate class. These are targeted synthetic drugs taken as tablets that work inside the cell on enzymes called Janus kinases. They are not biologics, but they come up in the same conversation because they are used at the same stage of treatment and are chosen for some of the same reasons.
Where biologic treatment for arthritis fits in the plan
Rheumatology works to a target. You and your rheumatologist agree what controlled disease would look like, treatment starts with a conventional disease-modifying drug, and the result is reviewed at set intervals. If the target has not been reached in a reasonable time, the treatment steps up rather than continuing unchanged.
Biologic treatment for arthritis is one of the steps up, and being offered it is not a judgement on how well you have followed advice. It means the inflammation has proved more stubborn than the first drug could handle.
For rheumatoid arthritis and psoriatic arthritis that usually means methotrexate first, alone or combined, given a fair trial before anything is called a failure. What to expect when methotrexate is started explains why six to twelve weeks is the earliest sensible point to judge it. The National Rheumatoid Arthritis Society notes that when someone does move on to a biologic for the first time, it is usually an anti-TNF drug or an anti-TNF biosimilar (NRAS).
Ankylosing spondylitis follows a different route. Conventional tablets do not control spinal inflammation, so for active axial disease the sequence runs from anti-inflammatory medicines and a committed exercise programme to a biologic, without a methotrexate stage in between. That is not a shortcut; it reflects what works where.
The main families, and what each one blocks
- TNF inhibitors. The oldest and most widely used family of biologics for rheumatoid arthritis, psoriatic arthritis and axial disease.
- Interleukin-6 blockade. Often chosen when a TNF inhibitor has not worked, and useful when a drug is needed without methotrexate alongside it.
- Interleukin-17 and interleukin-23 blockade. Particularly useful where skin psoriasis and joint disease travel together.
- B-cell depletion. Removes the antibody-producing cells; used in rheumatoid arthritis and in several forms of vasculitis and connective tissue disease.
- T-cell co-stimulation blockade. Interrupts the signal that activates T cells, an option when infection risk is a particular concern.
The choice between them is not a ranking. It depends on which disease you have, what else you live with, whether you are planning a pregnancy, whether skin, eye or bowel inflammation is part of the picture, and whether you would rather inject at home or attend for an infusion. Some pairings are avoided deliberately: certain drugs are unsuitable if there is a history of demyelinating disease, and others are avoided when inflammatory bowel disease is present.
Screening before the first dose
Nothing is started until a short list of checks is complete, and this is not a formality. Screening looks for infections that are dormant rather than obvious, because the treatment that follows will make it easier for them to wake up.
The usual set. Full blood count, liver and kidney function, hepatitis B and hepatitis C testing, and HIV testing where relevant. A chest X-ray, and testing for latent tuberculosis. Vaccination history, so that anything needed can be given before immune suppression begins. Rheumatology blood tests explained covers what the routine panels do and do not show.
Timing matters. Live vaccines cannot be given once treatment has started, so the gap before the first dose is the window for them. Infection risk and vaccination on immunosuppression sets out which vaccines are recommended and which are avoided.
Why tuberculosis screening matters especially in India
Latent tuberculosis screening is the one preparation step nobody here should skip. Latent infection means the bacteria are present in the body, walled off and causing no symptoms. TNF is one of the proteins that maintains that wall. Block it, and a dormant infection has a better chance of becoming active disease. The NHS lists reactivation of infections such as TB among the more serious problems that can follow biological treatment in people who have had them in the past (NHS).
This matters more here than in most places. The World Health Organization estimates that about a quarter of the global population has been infected with TB bacteria, and puts a quarter of the world's new TB cases in India (WHO). A negative screening test in Gurugram carries the same meaning as anywhere else; the difference is how often the test comes back positive.
If latent infection is found, it is treated first and the biologic is started afterwards, at a point your rheumatologist will specify. That delay is frustrating when you are in pain, and it is not negotiable.
Get seen quickly, not next week, if a cough lasts more than a couple of weeks, you have drenching night sweats, unexplained weight loss or a fever that keeps returning while on treatment. Tell whoever sees you that you are on a biologic, because it changes what they look for.
Injections, infusions and how a course is given
A biologic injection under the skin comes as a pre-filled pen or syringe, and you or a family member are taught to give it at home. Other drugs are given as an intravenous infusion in a day-care unit, which takes a few hours and needs a planned appointment (Arthritis Foundation).
Cold chain. Most of these drugs live in the fridge, not the freezer and not the door shelf. In a Delhi NCR summer, and during a power cut, that needs thinking about in advance. Carry them in an insulated pouch with a cool pack when you travel, and keep them in the cabin rather than checked baggage.
Missed and delayed doses. If a dose is missed, or you are unwell when one falls due, ask the clinic what to do rather than working it out yourself. Never double up to catch up, and speak to your rheumatologist before changing anything about the schedule you were given.
Biosimilars: the same target, a different manufacturer
A biosimilar is a version of an existing biologic made by another manufacturer after the original patent expires, approved on evidence that it behaves no differently in the body in any clinically meaningful way. Several are available in India, and for many people the first biologic they are offered is one.
A biosimilar is not a generic in the way a paracetamol tablet is a generic, because a living-cell product can never be copied atom for atom. It is held to a standard of no meaningful clinical difference instead. Switching between an original and a biosimilar is routine in practice.
One practical point: keep a note of the exact brand on the pen or vial you are given each time, and tell the clinic if it changes. If a side effect appears, the record of which product you were actually using is what makes it possible to work out why.
Infection risk, vaccines and sick days
Biologics increase the risk of infection, and of ordinary infections becoming more serious than they would otherwise be. That risk is real, it is manageable, and it is smaller than the risk of leaving active inflammatory disease to run.
- Fever, a productive cough, burning on passing urine or a hot swollen joint deserve prompt medical attention rather than a wait-and-see week.
- Most rheumatologists ask you to contact them before the next dose if you are running a fever or have been started on antibiotics.
- Annual influenza vaccination and pneumococcal vaccination are usually recommended; live vaccines are avoided during treatment.
- Any dentist, surgeon or physician treating you needs to know you are on a biologic, and planning treatment around surgery and dental work explains what that changes.
Household contacts matter too. If someone at home has active tuberculosis, chickenpox or shingles, tell the clinic rather than assuming it is unrelated.
What monitoring looks like once you are on treatment
Once biologic treatment for arthritis is under way, blood tests continue on a settled rhythm, watching blood counts and liver and kidney function. Alongside them, disease activity is scored at each review: swollen and tender joint counts, your own rating of how things are, and an inflammatory marker.
Response is judged over months, not weeks. If a drug has not delivered enough by the agreed review point, the options are to switch within the same family or to move to a different target. Switching is normal and is not a sign that treatment has failed you.
If the disease stays in remission for a sustained period, reducing treatment can be discussed. That usually means spacing doses further apart under supervision rather than stopping outright, because stopping altogether often brings the disease back. Remission is a state that treatment maintains, not a cure that treatment delivers. Details of how these drugs are used sit on the page about immunomodulation and biologic therapy.
What to bring to the appointment where this is decided
Come with the evidence, not the summary. A conversation about biologic treatment for arthritis moves much faster when the full history is on the table.
- Every previous prescription, including drugs that were stopped and the reason they were stopped.
- Blood reports in date order, so the trend is visible rather than a single recent value.
- Any chest X-ray, TB test result, or record of TB treatment or contact in the family.
- Your vaccination record, and the dates of anything given in the last few months.
- A list of other conditions, particularly diabetes, hepatitis, heart failure or recurrent infections.
- Your plans for pregnancy, if that is on the horizon for you or your partner.
If you are new to the clinic, what happens at a first rheumatology visit describes how the appointment is structured. Bring the packets and the paperwork, and expect the first conversation about a biologic to end with screening tests rather than a prescription.
Common questions
How long do biologics take to work?
Many people notice a difference within the first few weeks, which is faster than conventional tablets usually manage. The full answer takes longer: response is formally judged at a review some months in, using joint counts and inflammatory markers rather than how you felt on one good day.
Do I have to keep taking methotrexate with a biologic?
Often yes. Combining the two improves the response to several biologics and reduces the chance of the body making antibodies against the drug. Some biologics work well on their own, which matters if methotrexate was stopped for side effects. Your rheumatologist decides this for your specific drug.
Can I take a biologic if I have had TB before?
Usually yes, with preparation. Past or latent tuberculosis is not an automatic bar, but it is treated first and the biologic is started afterwards. Tell the clinic about any TB treatment you have had, any family member treated for TB, and any old chest X-ray you still have.
Are biologics safe to take for years?
They are used long term and are monitored long term. The main concern is infection, which is why blood tests continue and why fever is taken seriously. Weigh this against uncontrolled inflammation, which damages joints permanently. Regular review is what keeps the balance sensible.
Sources
- NHS - Rheumatoid arthritis: treatment www.nhs.uk
- NRAS - Biologics for rheumatoid arthritis nras.org.uk
- Arthritis Foundation - Biologic drugs for arthritis www.arthritis.org
- WHO - Tuberculosis fact sheet www.who.int
This article is general information and does not replace a consultation.